M Holdings Securities Inc. Has $1 Million Stake in Ishares Nasdaq Biotechnology (IBB)

M Holdings Securities Inc. lifted its position in Ishares Nasdaq Biotechnology (NASDAQ:IBB) by 222.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 4,976 shares of the financial services provider’s stock after buying an additional 3,432 shares during the period. M Holdings Securities Inc.’s holdings in Ishares Nasdaq Biotechnology were worth $1,003,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Tarbox Family Office Inc. raised its holdings in shares of Ishares Nasdaq Biotechnology by 200.0% during the fourth quarter. Tarbox Family Office Inc. now owns 1,059 shares of the financial services provider’s stock valued at $113,000 after purchasing an additional 706 shares during the last quarter. Bollard Group LLC increased its holdings in Ishares Nasdaq Biotechnology by 200.0% during the fourth quarter. Bollard Group LLC now owns 1,176 shares of the financial services provider’s stock valued at $126,000 after buying an additional 784 shares during the last quarter. Aua Capital Management LLC increased its holdings in Ishares Nasdaq Biotechnology by 200.0% during the fourth quarter. Aua Capital Management LLC now owns 1,200 shares of the financial services provider’s stock valued at $128,000 after buying an additional 800 shares during the last quarter. FNY Partners Fund LP purchased a new stake in Ishares Nasdaq Biotechnology during the third quarter valued at approximately $133,000. Finally, Edge Wealth Management LLC increased its holdings in Ishares Nasdaq Biotechnology by 381.8% during the fourth quarter. Edge Wealth Management LLC now owns 1,272 shares of the financial services provider’s stock valued at $136,000 after buying an additional 1,008 shares during the last quarter. Hedge funds and other institutional investors own 62.05% of the company’s stock.

How to Become a New Pot Stock Millionaire

IBB stock traded down $3.14 during midday trading on Friday, reaching $101.03. 2,840,400 shares of the company’s stock traded hands, compared to its average volume of 2,502,108. Ishares Nasdaq Biotechnology has a 52-week low of $94.20 and a 52-week high of $119.30.

COPYRIGHT VIOLATION NOTICE: This piece was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this piece can be read at https://www.dispatchtribunal.com/2018/04/08/ishares-nasdaq-biotechnology-index-ibb-holdings-raised-by-m-holdings-securities-inc.html.

Ishares Nasdaq Biotechnology Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Institutional Ownership by Quarter for Ishares Nasdaq Biotechnology (NASDAQ:IBB)

Receive News & Ratings for Ishares Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ishares Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply